The Investor Globe

  Home   |  Business   |  Personal Finance   |  Gold   |  World   |  USA   |  China   |  India   |  Middle East   |  Bitcoin   |  Techno   |  Blogs   |  M & A   |  IPO

Top Stories on Myriad Genetics

Myriad Genetics and Pharma Mar Enter Into Companion Diagnostic Agreement - Marketwatch

SALT LAKE CITY, Jul 26, 2012 (GlobeNewswire via COMTEX) -- Myriad Genetics, Inc. (NASDAQ:MYGN) today announced that it has signed an agreement with Pharma Mar, a leader in the development of marine-derived drugs. Under the agreement, Myriad will ...

Myriad Genetics (MYGN) Signs Diagnostic Agreement with Pharma Mar - StreetInsider.com

Myriad Genetics, Inc. (Nasdaq: MYGN) has signed an agreement with Pharma Mar, a leader in the development of marine-derived drugs. Under the agreement, Myriad will conduct BRCA 1 and BRCA 2 testing on patients to be enrolled in a Phase II clinical study of ...

ACLU argues Myriad Genetics DNA patent case -- again - Los Angeles Times

Appelate judges in Washington, D.C., heard arguments Friday in a case that has traveled from U.S. district court in New York to the federal appeals court to the Supreme Court and back again. At issue: Can a company patent a gene? In 2009, a group of ...

Myriad Genetics Files Supplemental Brief in AMP v. USPTO - jdsupra.com

Appellant Myriad Genetics (the real "target" in interest of the ACLU/PubPat lawsuit over isolated human DNA molecules) filed its Supplemental Brief pursuant to Federal Circuit order in the remand of AMP v. USPTO. Not surprisingly, the brief urges the Court ...

Bio-Rad and Myriad RBM Partner to Commercialize Multiplex Biomarker Kits for Life Science Research - Marketwatch

Myriad RBM is a wholly owned subsidiary of Myriad Genetics (MYGN). More information about Myriad RBM is available at www.myriadrbm.com . About Bio-Rad Bio-Rad Laboratories, Inc. (NYSE:BIO) and has remained at the center of scientific discovery ...

Myriad Genetics (MYGN) Showing Bullish Technicals But Could Break Through $25.75 Resistance - Market Intelligence Center

Thursday, July 19, 2012... Myriad Genetics (NASDAQ:MYGN) closed Wednesday's positive trading session at $25.90. In the past year, the stock has hit a 52-week low of $17.51 and..... Friday, July 13, 2012... Myriad Genetics (NASDAQ: MYGN) closed Thursday's ...

Myriad Defends Patent Claims on Genetic Material in Court Case - Businessweek

Myriad Genetics Inc. (MYGN) (MYGN), owner of patents related to genes linked to hereditary cancer risks, is trying to claim legal ownership of a product of nature, the American Civil Liberties Union told a U.S. appeals court today.

Myriad Genetics Inc. (MYGN) CFO James S Evans sells 15,400 Shares - GuruFocus

CFO of Myriad Genetics Inc. (MYGN) James S Evans sells 15,400 shares of MYGN on 07/18/2012 at an average price of $26.01 a share. Myriad Genetics, Inc. has a market cap of $2.17 billion; its shares were traded at around $25.9 with a P/E ratio of 20.3 and P ...
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
/script>
 

/script>
 
Blogspot logo    Latest Posts from Jim Rogers blog
Focus On Stocks That Are Not On The ETFs Radars
When The Bear Market Arrives...
The US Dollar Will Lose The Currency Reserve Status Fast
Investing: How To Be Successful
Gold Will Eventually Have An Epic Move Up
 
Blogspot logo    Latest Posts from Felix Zulauf blog
Felix Zulauf: Japan Will Be the Root Cause of the Next Global Crisis
Felix Zulauf Readies Hedge Fund With Son
FELIX ZULAUF: Stocks Remind Me Of Gold And They Could See A 'Quick And Painful Adjustment'
Felix Zulauf Recommended 7 Trades At Barron's Roundtable
Felix Zulauf's Yen for Japan
 
  Latest Posts from Mad Money 
Cramer?s Exec Cut: The benefits and dangers of advancing technology
Cramer Remix: The 2 distinct places investors should keep their cash
Cramer makes the bull case for including bonds in your portfolio
Cramer shares the best way to get your child excited about investing
Cramer: How compounding can help you double your money in 7 years
 
   Latest Posts from Fast Money
'Ugly correction' coming: Dennis Gartman
Your first trade for Tuesday
Retail terrified by EEM: Pro
Stock Pops & Drops: AOL, FEYE, JOSB & RYAAY
Second leg of bond rally: Pro
 
 Latest Posts from Bill Cara blog
Tables & Charts for Wednesday, Apr 17th, 2013
Bill Cara's Blog for Apr 17, 2013
Tables & Charts for Tuesday, Apr 16th, 2013
Bill Cara's Blog for Apr 16, 2013
Tables & Charts for Monday, Apr 15th, 2013
 
logo    Latest Posts from Kirk Report

Warning: MagpieRSS: Failed to parse RSS file. (XML_ERR_NAME_REQUIRED at line 1, column 2) in C:\Inetpub\vhosts\theinvestorglobe.com\httpdocs\rss_fetch.inc on line 414

Warning: array_slice() expects parameter 1 to be array, null given in C:\Inetpub\vhosts\theinvestorglobe.com\httpdocs\corporations-news.php on line 440

Warning: Invalid argument supplied for foreach() in C:\Inetpub\vhosts\theinvestorglobe.com\httpdocs\corporations-news.php on line 441
 
Blogspot logo    Latest Posts from Random Roger
Serious Retirement Downsizing
Planning Advice From True Experts
James Altucher is Right, Retirees Shouldn?t Own A Home
?You?ll Be Stone Dead In A Moment?
Rock You Like A Hurricane
 
  Home

  Business News
  Personal Finance
  World News
  U.S. News
  China News
  India News
  Middle East News
  Technology
  Blogs

  Mergers and Acquisitions
  IPO (initial Public Offering)
  Bernard Madoff
  Geneal Motors Bankruptcy
  Food prices crisis

  Sitemap
  Gold
  Silver
  Platinum
  Palladium
  Rhodium

         

               
                 Copyright Leaderglobe.